Owen N. Witte, Director at Allogene Therapeutics, Inc. (ALLO), sold 19,938 shares at $25.05 ($499K) on 2021-06-09, disclosed to the SEC on 2021-06-11.
Open-market sale of $499k ALLO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.05 | 9,969 | $250K | 50.0% |
| 2 | $25.05 | 9,969 | $250K | 50.0% |
| Total | $25.05 avg | 19,938 | $499K | 100% |
| Filing → |
| ALLO | SELL | 2021-09-09 | $128K | — | Filing → |
| ALLO | SELL | 2021-08-23 | $351K | — | Filing → |
| ALLO | BUY | 2018-10-17 | $270K | — | Filing → |